AGILON HEALTH INC (AGL) Institutional Ownership
None of the superinvestors we track currently report AGILON HEALTH INC (AGL) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in AGILON HEALTH INC (AGL), this page will show fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q4 2025 | 2 | $1,652,089 | 2,398,851 |
| Q3 2025 | 2 | $1,531,846 | 1,487,229 |
| Q2 2025 | 2 | $2,018,377 | 877,555 |
| Q1 2025 | 2 | $5,709,335 | 1,318,553 |
| Q4 2024 | 2 | $932,444 | 490,760 |
| Q3 2024 | 2 | $821,595 | 209,057 |
| Q2 2024 | 1 | $179,569 | 27,457 |
| Q1 2024 | 3 | $6,124,179 | 1,288,479 |
| Q4 2023 | 3 | $26,567,403 | 2,204,337 |
| Q3 2023 | 3 | $103,746,458 | 6,338,882 |
| Q2 2023 | 3 | $105,164,457 | 7,742,668 |
| Q1 2023 | 3 | $131,354,235 | 5,566,269 |
Related AGL Institutional Insights:
- AGL Institutional Ownership & Insiders Activity
- AGL Institutional Ownership & 13F Activity
- AGL Top Institutional Shareholders
- AGL Institutional Buying Activity
- AGL Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- AGL Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings